Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Middle East and Africa Checkpoint Inhibitors Market 2016-2021 with Competitors Analysis and Growth Opportunities

 



(PharmaNewsWire.Com, October 18, 2017 ) Middle East and Africa Checkpoint Inhibitors Market was worth USD 610 million in 2016 and is expected to reach USD 1590 million by 2021 with a CAGR of 27.19 %.



Checkpoint Inhibitors Industry are drugs used in Immunotherapy. They are generally made up of antibodies that lead an immune system attack on cancer cells. T-cells launches an attack when it detects infected or Cancerous. Immune system uses a series of molecules called checkpoint molecules to protect normal cells from attack. Cancer cells use these Checkpoints to escape T-cells by arraying themselves with Normal Cells. Checkpoint Inhibitors block these proteins on cancer cells which lets T-Cells launch an attack on Cancer cells.



View Full Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/



Increasing funding and government support towards developing new drugs and rising Prevalence of cancer globally are some of the factors driving the growth of the market. However, high R&D expense activities is one of the major factors responsible for restricting the growth of the market.



Middle East and Africa Checkpoint Inhibitors Market is categorized based on Drug type and Application. Based on Drug type, market is segmented into PD-L1 inhibitors, PD-1 inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, and Others. Based on Application, the market is segmented into Lung cancer, Blood cancer, Renal cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma, others. CTLA-4 segment holds the largest share accounting for almost 94 % of the overall market.



Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/request-sample



However, this segment is expected to drop some of its market share to PD-1 inhibitors segment during the mentioned period as majority of new treatments are based on PD-1 inhibitors. Geographically, market is further segmented into Middle East and Africa

Some of the major players in the Middle east and Africa checkpoint inhibitors market include Merck & Co., Inc., Roche, AstraZeneca, Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Novartis International AG, Juno Therapeutics, and Kite Pharma.



Market Segmentation



1) Drug Type

• Introduction

• PD-1 inhibitors

• PD-L1 inhibitors

• CTLA-4

• Chimeric Antigen Receptor T-cell

• Others

• Y-o-Y Growth Analysis, By Drug Type

• Market Attractiveness Analysis, By Drug Type

• Market Share Analysis, By Drug Type



2) Application

• Introduction

• Lung cancer

• Renal cancer

• Blood cancer

• Bladder Cancer

• Hodgkin lymphoma

• Melanoma

• Others

• Y-o-Y Growth Analysis, By Application

• Market Attractiveness Analysis, By Application

• Market Share Analysis, By Application



Inquire before Buying at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/inquire



Reasons to buy Middle East and Africa Checkpoint Inhibitors Market Research Report:



• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market



About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.



Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/



View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Market Data Forecast

Abhishek

+1-888- 702-9626

abhishek@marketdataforecast.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com ™ - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC